Aerpio Pharmaceuticals Inc.

2.07-0.0200-0.96%Vol 1.07M1Y Perf 37.50%
Jul 23rd, 2021 16:00 DELAYED
BID2.11 ASK2.18
Open2.14 Previous Close2.09
Pre-Market- After-Market-
 - -  - -%
Target Price
13.00 
Analyst Rating
Hold 3.00
Potential %
528.02 
Finscreener Ranking
★★★★★     59.01
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     58.20
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     60.86
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap98.28M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
47.26 
Earnings Date
11th Aug 2021

Today's Price Range

2.032.17

52W Range

0.95003.32

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.49%
1 Month
15.00%
3 Months
80.00%
6 Months
62.99%
1 Year
37.50%
3 Years
-50.48%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ARPO2.07-0.0200-0.96
AAPL148.561.76001.20
GOOG2 756.3289.75003.37
MSFT289.673.53001.23
XOM57.04-0.0700-0.12
WFC44.59-0.4400-0.98
JNJ171.791.81001.06
FB369.7918.60005.30
GE12.710.01000.08
JPM150.64-0.2900-0.19
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.09-0.0633.33
Q04 2020-0.13-0.1023.08
Q03 2020-0.14-0.1214.29
Q02 20200.270.23-14.81
Q01 2020-0.09-0.10-11.11
Q04 2019-0.12-0.0925.00
Q03 2019-0.12-0.118.33
Q02 2019-0.12-0.120.00
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.40-566.67Negative
9/2021 QR-0.40-566.67Negative
12/2021 FY-1.39-434.62Negative
12/2022 FY-1.82--
Next Report Date11th Aug 2021
Estimated EPS Next Report-0.40
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume1.07M
Shares Outstanding47.48M
Trades Count3.96K
Dollar Volume2.79M
Avg. Volume5.71M
Avg. Weekly Volume1.62M
Avg. Monthly Volume15.28M
Avg. Quarterly Volume10.24M

Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO) stock closed at 2.07 per share at the end of the most recent trading day (a -0.96% change compared to the prior day closing price) with a volume of 1.08M shares and market capitalization of 98.28M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 12 people. Aerpio Pharmaceuticals Inc. CEO is Joseph Gardner.

The one-year performance of Aerpio Pharmaceuticals Inc. stock is 37.5%, while year-to-date (YTD) performance is 111.22%. ARPO stock has a five-year performance of %. Its 52-week range is between 0.95 and 3.32, which gives ARPO stock a 52-week price range ratio of 47.26%

Aerpio Pharmaceuticals Inc. currently has a PE ratio of -22.90, a price-to-book (PB) ratio of 2.50, a price-to-sale (PS) ratio of 8.10, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -12.23%, a ROC of -13.50% and a ROE of -13.05%. The company’s profit margin is -32.26%, its EBITDA margin is -43.60%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Aerpio Pharmaceuticals Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.40 for the next earnings report. Aerpio Pharmaceuticals Inc.’s next earnings report date is 11th Aug 2021.

The consensus rating of Wall Street analysts for Aerpio Pharmaceuticals Inc. is Hold (3), with a target price of $13, which is +528.02% compared to the current price. The earnings rating for Aerpio Pharmaceuticals Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aerpio Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aerpio Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 29.47, ATR14 : 0.24, CCI20 : 17.93, Chaikin Money Flow : 0.04, MACD : 0.07, Money Flow Index : 89.52, ROC : 21.05, RSI : 52.33, STOCH (14,3) : 24.70, STOCH RSI : 0.39, UO : 46.73, Williams %R : -75.30), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aerpio Pharmaceuticals Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Hold
3.00

Aerpio Pharmaceuticals Inc.

Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product AKB-9778, is a Tie2 activator being developed for the treatment of diabetic eye disease. Other products under the pipeline are cc-1536 and c-4924.

CEO: Joseph Gardner

Telephone: +1 513 985-1920

Address: 9987 Carver Road, Cincinnati 45242, OH, US

Number of employees: 12

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

57%43%

Bearish Bullish

58%42%

News

Stocktwits